期刊文献+

^(18)F-FDG PET/CT诊断肾细胞癌 被引量:12

^(18)F-FDG PET/CT in diagnosis of renal cell carcinoma
下载PDF
导出
摘要 目的探讨^(18)F-FDG PET/CT诊断肾细胞癌(RCC)的价值。方法回顾性分析32例确诊为RCC患者的病理及PET/CT影像资料,比较不同病理类型(透明细胞癌与非透明细胞癌)、Fuhrman分级(高级别与低级别透明细胞癌)和临床分期(有无远处转移)RCC的肿瘤直径和最大标准摄取值(SUV_(max))差异。结果 32例患者共33个原发灶,PET/CT检出31个,2个假阴性,检出率为93.94%(31/33)。31个原发灶PET/CT表现为肾实质内混杂密度的软组织团块,其^(18)F-FDG摄取可接近、高于或低于正常肾实质;2个原发灶PET/CT未见异常表现。8例伴静脉瘤栓,19例伴远处转移,瘤栓及转移灶的FDG摄取均高于受累器官本底。不同病理类型组和不同Fuhrman分级RCC的肿瘤最长径及SUV_(max)差异无统计学意义;不同临床分期RCC的肿瘤最长径差异无统计学意义,SUV_(max)差异有统计学意义(t=3.852,P=0.001)。结论 RCC原发灶的PET/CT表现多样,较小的低级别肾透明细胞癌可无明显异常表现而漏诊;18 F-FDG PET/CT在RCC术前分期中具有重要价值。 Objective To evaluate the value of ^18F-FDG PET/CT in diagnosis of renal cell carcinoma (RCC). Methods Totally 32 patients with RCC confirmed by pathology were analyzed retrospectively. The tumor diameter and maximum standard uptake values (SUVmax) of different pathological types (clear and none clear RCC), different Fuhrman grades (high grade and low grade of clear RCC) and different clinical stages (distant and without distant metastases) were analyzed and compared. Results 32 RCC patients including 33 primary tumors, 31 lesions were detected by PET/CT and 2 were false negative, the detection rate was 93.94%. The PET/CT findings of 31 primary lesions were mixed density soft tissue masses, and the 18F-FDG uptake accessible, above or below to the normal renal parenchyma; the other 2 lesions of PET/CT findings were normal. 18F-FDG uptake of vein tumor thrombus in 8 cases and metastases in 19 cases were higher than the organs affected. The tumor diameter and SUVmax had no statistically significant difference in different pathological types and Fuhrman grades; The tumor diameter had no statistically significant difference, and SUVmax had statistically significant (t=3.852, P=0.001) between different clinical stages. Conclusion The PET/CT findings of RCC primary lesion are varied, and small clear RCC with low Furhman grade may have no obvious abnormality and missed diagnosis; ^18F-FDG PET/CT has important value in the preoperative staging of RCC.
出处 《中国医学影像技术》 CSCD 北大核心 2017年第4期571-575,共5页 Chinese Journal of Medical Imaging Technology
关键词 肾细胞 正电子发射断层显像术 体层摄影术 X线计算机 氟脱氧葡萄糖F18 Carcinoma, renal cell Positron-emission tomography Tomography, X-ray computed Fluorodexyglucose F18
  • 相关文献

参考文献4

二级参考文献52

  • 1陆明园,温淑英,郑鹏宇,孙晓光,王毅纯.囊性肾癌的CT诊断[J].中国医学影像技术,2008,24(S1):143-144. 被引量:15
  • 2王荣福,张建华,张春丽,范岩,付占立,张旭初,胡怀湘,何晓坤,林景辉,郭凤琴,赵光宇,王彦福,田红.符合线路单光子发射型计算机断层双时相显像鉴别病变性质的临床应用价值[J].北京大学学报(医学版),2005,37(3):287-291. 被引量:7
  • 3邵志强,郑少斌,谭万龙,陈彤,齐桓,姜耀东,肖耀军,张辉见.F-18FDG-PET对肾细胞癌诊治临床作用初步研究[J].滨州医学院学报,2005,28(3):185-186. 被引量:4
  • 4俞建华,王荣福.正电子发射断层代谢显像标准摄取值及定量分析的问题与对策[J].中国医学影像技术,2005,21(5):791-794. 被引量:11
  • 5Wahl RL,Harney J,Hutchins G,et al.Imaging of renal cancer using positron emission tomography with2-deoxy-2-(18-F)-fluo-ro-D-glucose:Pilot animal and human studies.J Urol,1991,146(6):1470-1474.
  • 6Aide N,Cappele O,Bottet P,et al.Efficiency of[(18)F] FDG PET in characterising renal cancer and detecting distant metasta-ses:A comparison with CT.Eur J Nucl Med Mol Imaging,2003,30(9):1236-1245.
  • 7Kang DE,White Jr RL,Zuger JH,et al.Clinical use of fluorode-oxyglucose F18positron emission tomography for detection of re-nal cell carcinoma.J Urol,2004,171(5):1806-1809.
  • 8Majhail NS,Urbain JL,Albani JM,et al.F-18fluorodeoxyglu-cose positron emission tomography in the evaluation of distant me-tastases from renal cell carcinoma.J Clin Oncol,2003,21(6):3995-4000.
  • 9Montravers F,Grahek D,Kerrou K,et al.Evaluation of FDG uptake by renal malignancies(primary tumor or metastases)using a coincidence detection gamma camera.J Nucl Med,2000,41(1):78-84.
  • 10Ozülker T,Ozülker F,Ozbek E,et al.A prospective diagnostic accuracy study of F-18fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indetermi-nate renal masses.Nucl Med Commun,2011,32(4):265-272.

共引文献21

同被引文献71

引证文献12

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部